Pakistan’s Pharmaceuticals Sector Sees Strong Profits Amid Deregulation and Cost Declines
Karachi: Pakistan’s listed pharmaceuticals sector reported a significant increase in earnings, rising by 30% year-on-year to reach Rs10.4 billion in the first quarter of fiscal year 2026. The surge in profitability is largely driven by increased net s…